AB PT cmplx conc kcentra lab
Ended Awarded Last action
- Contract number
- SPE2DR26FKKE4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,161
Award facts
- Contract value 100% obligated
- $17,160.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,160.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, is issued without a set-aside designation and represents one of numerous purchase orders DMS has received from the DLA's Medical Supply Chain division. The delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors.
DMS Pharmaceutical Group's PPV-G GEN V contract, awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period plus three 30-month option periods. Under this umbrella vehicle, the company supplies a comprehensive range of pharmaceutical products to Department of Defense healthcare facilities worldwide, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals and medical consumables. The current delivery order for materials designated as "AB PT CMPLX CONC KCENTRA LAB" reflects DMS's established performance capacity to fulfill the diverse and specialized pharmaceutical requirements supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FKKE4?
SPE2DR26FKKE4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FKKE4 worth?
The government has obligated $17,161 on SPE2DR26FKKE4.
Is contract SPE2DR26FKKE4 an order under another contract?
Yes. SPE2DR26FKKE4 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKE4 competed?
The extent of competition for SPE2DR26FKKE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award